Research Article
Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases
Table 2
Clinical characteristics of cervical neuroendocrine tumours.
| | Patient name | Age | Stage | Surgical procedure by | Type of surgery | Tumour diameter (cm) | Recurrence status | Preoperative CRT (C + E) | Postoperative CRT (C + E) | PFS (mo) | OS (mo) | Status |
| | Ü.S. | 65 | 2b | L/T | Type III RH + BSO + BPPLND | 12 | + | | + | 7 | 12 | Dead | | Z.A. | 70 | 2b | L/T | Type III RH + BSO + BPPLND | 5 | − | | + | 20 | 20 | Dead | | T.Ö. | 33 | 1b2 | L/T | Type III RH + BSO + BPPLND | 3 | − | | + | 208 | 208 | Alive | | M.U. | 78 | 1b2 | L/T | Type III RH + BSO + BPLND | 2, 5 | − | | + | 139 | 139 | Dead | | Y.A. | 78 | 2b | — | — | | + | + | | 14 | 26 | Dead | | Ş.Ç. | 39 | 3c2r | L/S | Lymphadenectomy | | − | + | | 120 | 120 | Alive | | A.D. | 48 | 1b2 | L/S | Type III RH + BSO + BPPLND | 3, 2 | − | | + | 36 | 36 | Alive | | E.K. | 58 | 2b | L/T | Type III RH + BSO + BPPLD | 10 | + | | + | 16 | 24 | Alive | | M.F.A | 58 | 4b | — | — | | − | + | | 6 | 6 | Dead |
|
|
L/T: laparotomy; L/S: laparoscopy; RH + BSO + BPPLND: radical hysterectomy + bilateral salpingoophorectomy + bilateral pelvic paraaortic lymphadenectomy; mo: month; C + E: cisplatin + etoposide.
|
